Appropriate and Effective Collaboration with Industry
1:30 PM - 3:00 PM
Friday, January 24
This session will examine the scope of medical consulting and potential for conflict of interest (COI). We will examine how COI is managed in the sphere of Neuromodulation compared to other sectors of organized medicine. We will discuss the implications of COI for physicians as individuals and collectively.
Learning Objectives
Upon completion of this educational activity, participants should be able to:
- Describe the scope of medical consulting and physician engagement.
- Discuss how a conflict of interest is handled in organized medicine both within and outside of Neuromodulation, including financial thresholds, research involvement, and speaking engagements.
- Explain how individual physicians can best manage conflicts of interest and the implications of COI disclosure.
- Indicate how industry-sponsored speakers and industry-sponsored research impacts physician decision making and clinical care.
The History of Industry Involvement in Medicine and The Future Trajectory
Peter Konrad, MD PhD
Consulting: The Ups and Downs
Jessica Jameson, MD
Industry and Research
Jonathan D. Carlson, MD
Managing Conflicts of Interest and The Impact on Clinical Decision Making
Padma Gulur, MD
Faculty and Presentations subject to change.
Tagged under
Related items
- Professional Development Workshop
- Thematic Abstract Presentations
- Plenary Session I -- What We Have Learned About Placebo: Implications for Clinical Practice and the Interpretation of Evidence About Analgesics
- Plenary Session II -- When It's Time to Say No: Patient Selection
- Emerging Indications for Deep Brain Stimulation
- Faculty:
- Location:
- Caesars Palace
- Moderators: